223 related articles for article (PubMed ID: 31520213)
21. Total pelvic exenteration for the treatment of advanced primary or recurrent pelvic neoplasia.
Carballo L; Enríquez-Navascués JM; Saralegui Y; Placer C; Timoteo A; Borda N; Carrillo A; Sainz-Lete A
Cir Esp; 2015 Mar; 93(3):174-80. PubMed ID: 25443154
[TBL] [Abstract][Full Text] [Related]
22. Extended lateral pelvic sidewall excision (ELSiE): an approach to optimize complete resection rates in locally advanced or recurrent anorectal cancer involving the pelvic sidewall.
Shaikh I; Aston W; Hellawell G; Ross D; Littler S; Burling D; Marshall M; Northover JM; Antoniou A; Jenkins JT
Tech Coloproctol; 2014 Dec; 18(12):1161-8. PubMed ID: 25380742
[TBL] [Abstract][Full Text] [Related]
23. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
[TBL] [Abstract][Full Text] [Related]
24. Pelvic exenteration for chronic fistulating pelvic sepsis after multimodal treatment of pelvic malignancy.
Brown KGM; Risbey C; Solomon MJ; Austin KKS; Lee PJ; Byrne CM
Eur J Surg Oncol; 2023 Dec; 49(12):107124. PubMed ID: 37879161
[TBL] [Abstract][Full Text] [Related]
25. Total Pelvic Exenteration for Locally Advanced and Recurrent Rectal Cancer: Urological Outcomes and Adverse Events.
Khan O; Patsouras D; Ravindraanandan M; Abrar MM; Schizas A; George M; Malde S; Thurairaja R; Khan MS; Sahai A
Eur Urol Focus; 2021 May; 7(3):638-643. PubMed ID: 32622667
[TBL] [Abstract][Full Text] [Related]
26. Comparing minimally invasive surgical and open approaches to pelvic exenteration for locally advanced or recurrent pelvic malignancies - Systematic review and meta-analysis.
Ryan OK; Doogan KL; Ryan ÉJ; Donnelly M; Reynolds IS; Creavin B; Davey MG; Kelly ME; Kennelly R; Hanly A; Martin ST; Winter DC
Eur J Surg Oncol; 2023 Aug; 49(8):1362-1373. PubMed ID: 37087374
[TBL] [Abstract][Full Text] [Related]
27. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Impact of Intra-abdominal/Pelvic Inflammation After Radical Surgery for Locally Recurrent Rectal Cancer.
Tanaka M; Kanemitsu Y; Shida D; Ochiai H; Tsukamoto S; Nagino M; Moriya Y
Dis Colon Rectum; 2017 Aug; 60(8):827-836. PubMed ID: 28682968
[TBL] [Abstract][Full Text] [Related]
29. Laterally Extended Pelvic Resection for Gynaecological Malignancies: A Multicentric Experience with Out-of-the-Box Surgery.
Vizzielli G; Naik R; Dostalek L; Bizzarri N; Kucukmetin A; Tinelli G; Scambia G; Cibula D
Ann Surg Oncol; 2019 Feb; 26(2):523-530. PubMed ID: 30539489
[TBL] [Abstract][Full Text] [Related]
30. Urological reconstruction after pelvic oncological surgery: A single institution experience.
Tan YG; Tan G; Tan D; Chia CS; Ang DY; Teo MCC
Asian J Surg; 2017 Sep; 40(5):389-395. PubMed ID: 27317102
[TBL] [Abstract][Full Text] [Related]
31. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
32. Total pelvic exenteration with preservation of fecal continence.
Brodsky JT; Sloane BB; Khanna OP
J Surg Oncol; 1993 Aug; 53(4):261-4. PubMed ID: 8341059
[TBL] [Abstract][Full Text] [Related]
33. Pelvic Exenteration for Locally Advanced and Relapsed Pelvic Malignancies - An Analysis of 100 Cases.
Bacalbasa N; Balescu I; Vilcu M; Neacsu A; Dima S; Croitoru A; Brezean I
In Vivo; 2019; 33(6):2205-2210. PubMed ID: 31662557
[TBL] [Abstract][Full Text] [Related]
34. Pelvic exenteration for advanced pelvic malignancies.
Yu HH; Leong CH; Ong GB
Aust N Z J Surg; 1976 Aug; 46(3):197-201. PubMed ID: 1070292
[TBL] [Abstract][Full Text] [Related]
35. The Price We Pay for Radical Curative Pelvic Exenterations: Prevalence and Management of Pain.
Lim JS; Koh CE; Liu H; Solomon MJ; Johnstone CSH
Dis Colon Rectum; 2018 Mar; 61(3):314-319. PubMed ID: 29420427
[TBL] [Abstract][Full Text] [Related]
36. Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome.
Andikyan V; Khoury-Collado F; Gerst SR; Talukdar S; Bochner BH; Sandhu JS; Abu-Rustum N; Sonoda Y; Barakat RR; Chi DS
Gynecol Oncol; 2012 Sep; 126(3):346-50. PubMed ID: 22555107
[TBL] [Abstract][Full Text] [Related]
37. [Results of laparoscopic pelvic exenterations].
Sanzharov AE; Gallyamov EA; Sergeev VP; Biktimirov RG; Aminova LN; Kochkin AD; Meshchankin IV; Agapov MA; Gololobov GY
Khirurgiia (Mosk); 2022; (7):45-57. PubMed ID: 35775844
[TBL] [Abstract][Full Text] [Related]
38. Pelvic local recurrence from colorectal cancer: surgical challenge with changing preconditions.
Iversen H; Martling A; Johansson H; Nilsson PJ; Holm T
Colorectal Dis; 2018 May; 20(5):399-406. PubMed ID: 29161761
[TBL] [Abstract][Full Text] [Related]
39. Preemptive Femoral-Femoral Crossover Grafting of Artery and Vein Before Pelvic Exenterative Surgery for Locally Advanced and Recurrent Pelvic Malignancy Involving the Aortoiliac Axis.
Peacock O; Smith N; Waters PS; Park-Yun Cheung F; McCormick JJ; Warrier SK; Wagner T; Heriot AG
Dis Colon Rectum; 2021 Jan; 64(1):e2-e5. PubMed ID: 33306540
[TBL] [Abstract][Full Text] [Related]
40. Surgical outcomes in pelvic exenteration for advanced and recurrent malignancy: a high volume single institution experience.
De Crignis L; Dupré A; Meeus P; Peyrat P; Rivoire M
Langenbecks Arch Surg; 2023 Jun; 408(1):221. PubMed ID: 37261533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
